6-K
Report of Foreign Issuer
Cellyan Biotechnology Co., Ltd Filed Acc 0001213900-25-122811
Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
From the SEC's structured data for this filing
Loading ea0270002-6k_hongkong.htm…